Submitted by fdagov3951 in business
FDA approves Roctavian, the first gene therapy for treatment of adults with severe hemophilia A.
Submitted by fdagov3951 in business
FDA approves Roctavian, the first gene therapy for treatment of adults with severe hemophilia A.